Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 1.4.3.4 extracted from

  • Culpepper, L.; Kovalick, L.J.
    A review of the literature on the selegiline transdermal system: an effective and well-tolerated monoamine oxidase inhibitor for the treatment of depression (2008), Prim. Care Companion J. Clin. Psychiatry, 10, 25-30.
    View publication on PubMedView publication on EuropePMC

Application

Application Comment Organism
medicine selegiline is an effective and well-tolerated monoamine oxidase inhibitor for the treatment of depression. The selegiline transdermal system provides several advantages compared to orally administered monoamine oxidase inhibitors, including minimal interaction with dietary tyramine and prolonged exposure to the parent compound, while offering a favorable side effect profile. Treatment at the lowest effective dose of 6 mg/24 hours can be administered without the need for dietary modifications Homo sapiens

Inhibitors

Inhibitors Comment Organism Structure
selegiline an effective and well-tolerated monoamine oxidase inhibitor for the treatment of depression Homo sapiens

Organism

Organism UniProt Comment Textmining
Homo sapiens
-
-
-